Imaging Technology

Olympus Launches Combined Imaging Mode to Enhance Cancer Detection Capabilities

Olympus Launches Combined Imaging Mode to Enhance Cancer Detection Capabilities

Olympus Corporation has introduced a new NBI+TXI observation mode for its EVIS X1 endoscopy system that combines two advanced imaging technologies to improve detection and diagnostic accuracy for gastrointestinal and respiratory cancers, addressing Japan's high cancer incidence rates.

October 29, 2025
CMS Decision on CT Radiation Standards Highlights Industry Shift Toward Low-Dose Imaging Technology

CMS Decision on CT Radiation Standards Highlights Industry Shift Toward Low-Dose Imaging Technology

The CMS proposal to keep CT radiation dose tracking voluntary underscores the ongoing tension between regulatory requirements and clinical needs, positioning companies like Izotropic with their low-dose breast CT technology at the forefront of evolving imaging standards.

September 26, 2025
Izotropic Corp. Launches Brand Transformation Ahead of Breast CT Technology Commercialization

Izotropic Corp. Launches Brand Transformation Ahead of Breast CT Technology Commercialization

Izotropic Corporation has unveiled a comprehensive brand identity transformation to position itself for the commercial launch of its revolutionary breast CT imaging technology targeting the $8.7 billion global breast imaging market.

August 26, 2025
Izotropic Corporation Announces $300K Private Placement and Warrant Extension for Breast Cancer Imaging Technology

Izotropic Corporation Announces $300K Private Placement and Warrant Extension for Breast Cancer Imaging Technology

Izotropic Corporation's $300,000 private placement and warrant extension provides crucial working capital to advance its breast cancer imaging technology development.

August 26, 2025
New Scanning Method Research Funded to Improve Brain Tumor Treatment

New Scanning Method Research Funded to Improve Brain Tumor Treatment

Researchers from NHS Grampian and the University of Aberdeen receive funding to explore a novel scanning method that could enhance the treatment of aggressive brain tumors, specifically glioblastomas.

June 25, 2025
Quantum BioPharma Advances MS Research with Groundbreaking PET Imaging Study

Quantum BioPharma Advances MS Research with Groundbreaking PET Imaging Study

Quantum BioPharma Ltd. has initiated a pioneering PET imaging study with Massachusetts General Hospital to track myelin integrity in multiple sclerosis patients, potentially revolutionizing treatment evaluation.

June 17, 2025